Showing 4,081 - 4,100 results of 101,664 for search '(( 50 ((ns decrease) OR (mean decrease)) ) OR ( 5 ((ng decrease) OR (a decrease)) ))', query time: 1.40s Refine Results
  1. 4081
  2. 4082
  3. 4083
  4. 4084
  5. 4085
  6. 4086
  7. 4087
  8. 4088
  9. 4089

    Combination metabolic therapy decreases VM-M3 cell proliferation <i>in vitro</i>. by A. M. Poff (752552)

    Published 2015
    “…Cell density was measured with trypan blue hemocytometry to produce a growth curve over 96 hours. <b>(A)</b> Proliferation of VM-M3 cells was inhibited with decreasing glucose concentration and the addition of HBOT. …”
  10. 4090
  11. 4091

    Modulation of Nogo-A and CaM Kinase II protein levels by running wheel exercise in primary motor cortex. by Jörg H. Stehle (10751557)

    Published 2021
    “…After 7 days of exercise, Nogo-A protein levels significantly decreased in M1 L2/3 (***: <i>P</i> = 0.001), but not in M1 L5 (a). …”
  12. 4092
  13. 4093

    Loss of Pcgf5 results in reduction in global H2AK119 levels. by Sha Si (2635147)

    Published 2016
    “…<p>(A) H2AK119ub1 levels in LK cells. LK cells from BM of WT and <i>Pcgf5</i><sup><i>Δ/Δ</i></sup> mice were analyzed by Western blotting using anti-H2AK119ub1 and anti-H3K27me3 antibodies at 1-month post deletion of <i>Pcgf5</i>. …”
  14. 4094
  15. 4095
  16. 4096
  17. 4097
  18. 4098
  19. 4099

    Combination metabolic therapy decreases VM-M3 cell viability <i>in vitro</i>. by A. M. Poff (752552)

    Published 2015
    “…<b>(A-B)</b> βHB, LG, and LG+βHB+HBOT treatment decreased viability compared to control and HBOT treated cells. …”
  20. 4100

    Inhibition of SHP-2 activity decreases <i>C</i>. <i>parvum</i> infectivity. by Eunice A. Varughese (824701)

    Published 2015
    “…<p>A) Dose-dependent decrease of Infections per field of view (y-axis) after treatment of FHs 74 Int cells with increasing concentrations of the SHP-2-specific inhibitor, SHP-2 PTPase Inhibitor. …”